共 27 条
[1]
Mechanisms of disease:pathogenesis of Crohn‘s disease and ulcerative colitis. Sartor RB. Nat Clin Pract Gastroenterol Hepatol . 2006
[2]
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease. Orlando A,Armuzzi A,Papi C,et al. Digestive and Liver Disease . 2011
[3]
Differentia-ting ulcerative colitis from crohn disease in children and young adults:Report of a Working Group of the North American Society for PediatricGastroenter ology,Hepatology,and Nutrition and the Crohn’’s and ColitisFoundation of America. North American Society for Pediatric Gastroenterology,Hepatology,andNutrition,Colitis Foundation of America,Bousvaros A,et al. Journal of Pediatric Gastroenterology and Nutrition . 2007
[4]
Long-term outcome of treat-ment with infliximab in 614 patients with Crohn’’s disease:Results froma single-centre cohort. Schnitzler F,Fidder H,Ferrante M,et al. Inflammatory Bowel Diseases . 2010
[5]
Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. Jensen MK,Tipnis NA,Bajorunaite R, et al. Gastrointestinal Endoscopy . 2010
[6]
Definition of phenotypic characteristics of childhood-onsetinflammatory bowel disease. Van Limbergen J,Russell RK,Drummond HE,et al. Gastroenterology . 2008
[8]
Nutritional status and nutritional therapy in inflammatory bowel diseases[J]. Corina Hartman,Rami Eliakim,Raanan Shamir. World Journal of Gastroenterology. 2009(21)
[10]
中国大陆地区炎症性肠病肠外表现的汇总分析[J]. 郑连鹏,吕宗舜,张洁,曹晓沧,王绪霖. 世界华人消化杂志. 2009(21)